Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas

NCT07319676 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

B-cell Lymphoma Refractory

Interventions

OTHER: CART infusion

Sponsor

National University Hospital, Singapore